摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-amino-2-methyl-1,2-dihydropyrazol-3-one | 74530-10-2

中文名称
——
中文别名
——
英文名称
5-amino-2-methyl-1,2-dihydropyrazol-3-one
英文别名
5-Amino-2-methyl-1,2-dihydro-pyrazol-3-on;3-amino-1-methyl-1H-pyrazol-5-ol;5-amino-2-methyl-1H-pyrazol-3-one
5-amino-2-methyl-1,2-dihydropyrazol-3-one化学式
CAS
74530-10-2
化学式
C4H7N3O
mdl
MFCD18909318
分子量
113.119
InChiKey
YGVFIVSNVVUSCS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    185.2±43.0 °C(Predicted)
  • 密度:
    1.240±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    58.4
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    5-amino-2-methyl-1,2-dihydropyrazol-3-one六氟乙酰丙酮溶剂黄146 作用下, 反应 2.0h, 以86%的产率得到2-methyl-4,6-bis(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-3(2H)-one
    参考文献:
    名称:
    带有1 H-吡唑并[3,4- b ]吡啶3-3 (2 H)-one核心的Deazapurine类似物:合成和生物活性
    摘要:
    为氟化和非氟化的1的合成的新方法ħ -吡唑并[3,4- b ]吡啶-3-酮被开发。反应是通过将富含电子的3-氨基-1 H-吡唑-5(4 H)-1与1,3-二酮环化而进行的,所获得的产物具有良好的产率和极好的区域选择性。该产品可被视为脱氮嘌呤类似物,已测试了碱性磷酸酶(h- TNAP和h- IAP)和核苷酸焦磷酸酶/磷酸二酯酶(h- NPP1和h‐NPP3)抑制曲线。大多数衍生物对组织非特异性和肠道碱性磷酸酶和核苷酸焦磷酸酶(NPP1和NPP3)酶表现出选择性和有效的抑制作用。通过分子对接分析研究了最有效抑制剂的可能结合方式。
    DOI:
    10.1002/ejoc.201800163
  • 作为产物:
    参考文献:
    名称:
    Synthesis of 2-Aminonicotinamides by Raney Nickel Cleavage of Pyrazolo[3,4-b]-pyridines1
    摘要:
    DOI:
    10.1021/ja01519a043
点击查看最新优质反应信息

文献信息

  • Deazapurine Analogues Bearing a 1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridin-3(2<i>H</i>)-one Core: Synthesis and Biological Activity
    作者:Linda Supe、Saira Afzal、Abid Mahmood、Syeda Abida Ejaz、Martin Hein、Viktor O. Iaroshenko、Alexander Villinger、Joanna Lecka、Jean Sévigny、Jamshed Iqbal、Peter Langer
    DOI:10.1002/ejoc.201800163
    日期:2018.6.7
    new methodology for the synthesis of fluorinated and non‐fluorinated 1H‐pyrazolo[3,4‐b]pyridin‐3‐ones was developed. The reactions proceed by cyclization of electron‐rich 3‐amino‐1H‐pyrazol‐5(4H)‐ones with 1,3‐diketones and the products were obtained in good to excellent yields and with excellent regioselectivity. The products, which can be regarded as deazapurine analogues, were tested for the alkaline
    为氟化和非氟化的1的合成的新方法ħ -吡唑并[3,4- b ]吡啶-3-酮被开发。反应是通过将富含电子的3-氨基-1 H-吡唑-5(4 H)-1与1,3-二酮环化而进行的,所获得的产物具有良好的产率和极好的区域选择性。该产品可被视为脱氮嘌呤类似物,已测试了碱性磷酸酶(h- TNAP和h- IAP)和核苷酸焦磷酸酶/磷酸二酯酶(h- NPP1和h‐NPP3)抑制曲线。大多数衍生物对组织非特异性和肠道碱性磷酸酶和核苷酸焦磷酸酶(NPP1和NPP3)酶表现出选择性和有效的抑制作用。通过分子对接分析研究了最有效抑制剂的可能结合方式。
  • Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
    申请人:——
    公开号:US20020007059A1
    公开(公告)日:2002-01-17
    Compounds of formula I 1 are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    公式I的化合物在治疗由钾通道开放剂预防或改善的疾病中很有用。还公开了钾通道开放组合物和在哺乳动物中开放钾通道的方法。
  • 3-(Dichloroacetyl)chromone; A New Building Block for the Synthesis of Formylated Purine Isosteres: Design and Synthesis of Fused α-(Formyl)pyridines
    作者:Viktor Iaroshenko、Peter Langer、Satenik Mkrtchyan、Gagik Ghazaryan、Ani Hakobyan、Aneela Maalik、Linda Supe、Alexander Villinger、Andrei Tolmachev、Dmytro Ostrovskyi、Vyacheslav Sosnovskikh、Tariel Ghochikyan
    DOI:10.1055/s-0030-1258364
    日期:2011.2
    The first synthesis of 3-(dichloroacetyl)chromone from 3-(dimethylamino)-1-(2-hydroxyphenyl)propen-1-one and dichloroacetyl chloride is described. The reaction of electron-rich aminoheterocycles with 3-(dichloroacetyl)chromone provides a set of diverse fused pyridines bearing the CHCl2-substituent at the α-position of the pyridine core. Subsequent hydrolysis leads to the formation of annulated α-(formyl)pyridines
    描述了由3-(二甲基氨基)-1-(2-羟基苯基)丙烯-1-酮和二氯乙酰氯首次合成3-(二氯乙酰基)色酮。富电子的氨基杂环与3-(二氯乙酰基)色酮的反应提供了一组不同的稠合吡啶,其在吡啶核的α-位带有CHCl 2-取代基。随后的水解导致环状的α-(甲酰基)吡啶的形成。 3-(二氯乙酰基)色酮-4 H -1-苯并吡喃-4-酮-杂环胺-稠合吡啶-环化反应
  • 3-Methoxalylchromone—a novel versatile reagent for the regioselective purine isostere synthesis
    作者:Satenik Mkrtchyan、Viktor O. Iaroshenko、Sergii Dudkin、Ashot Gevorgyan、Marcelo Vilches-Herrera、Gagik Ghazaryan、Dmitriy M. Volochnyuk、Dmytro Ostrovskyi、Zeeshan Ahmed、Alexander Villinger、Vyacheslav Ya. Sosnovskikh、Peter Langer
    DOI:10.1039/c0ob00379d
    日期:——
    The first synthesis of 3-methoxalylchromone was described. The reaction of the latter with electron-rich aminoheterocycles afforded a set of heteroannelated pyridines bearing a CO2Me substituent located at the α-position of the pyridine core.
    首次描述了 3-甲氧基苯丙酮的合成。后者与富含电子的氨基杂环反应后,得到了一组杂环吡啶,其吡啶核心的δ位上带有 CO2Me 取代基。
  • Structure–activity studies for a novel series of tricyclic dihydropyridopyrazolones and dihydropyridoisoxazolones as KATP channel openers
    作者:Irene Drizin、Robert J. Altenbach、Steven A. Buckner、Kristi L. Whiteaker、Victoria E. Scott、John F. Darbyshire、Venkata Jayanti、Rodger F. Henry、Michael J. Coghlan、Murali Gopalakrishnan、William A. Carroll
    DOI:10.1016/j.bmc.2004.01.038
    日期:2004.4
    In search of a novel chemotype of KATP channel openers a series of tricyclic dihydropyridopyrazolones and dihydropyridoisoxazolones was synthesized. It was found that cyclopentanone in the left hand portion of the molecule was 4-fold more potent than cyclohexanone. Introduction of gem-dimethyl groups as well as incorporation of oxygen in the cyclohexanone ring in the left hand portion of the molecule increased the potency 10-fold. In the right hand portion of the molecule, the NH-group of the pyrazolone can be effectively substituted by oxygen increasing the activity 5-fold. Incorporation of a methyl group adjacent to the dihydropyridine (DHP) nitrogen not only significantly boosted activity, but also provided an additional benefit of increased metabolic stability. In vitro tests on the tissue from pig bladder strips provided further confirmation of K-ATP activity of these compounds. (C) 2004 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] 香豆素-6-羧酸 锌离子载体IV 钐(III) 离子载体 II 苯,(2,2-二氟乙烯基)- 聚二硫二噻唑烷 缩胆囊肽9 甲酰乙内脲 甲巯咪唑 甲基羟甲基油基噁唑啉 甲基5-羟基-3,5-二甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-氰基-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基5-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-5-氧代-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4,5-二氮杂螺[2.4]庚-5-烯-6-羧酸酯 甲基4,5-二氢-5-乙基-1H-吡唑-1-羧酸酯 甲基(E)-3-[6-[1-羟基-1-(4-甲基苯基)-3-(1-吡咯烷基)丙基]-2-吡啶基]丙烯酰酸酯 甲基(5-氧代-4,5-二氢-1,2-恶唑-3-基)乙酸酯 环戊二烯并[d]咪唑-2,5(1H,3H)-二硫酮 溶剂黄93 溴化1-十六烷基-3-甲基咪唑 溴化1-十二烷基-2,3-二甲基咪唑 泰比培南酯中间体 泰比培南酯中间体 氨基甲硫酸,[2-[[(2-羰基-1-咪唑烷基)硫代甲基]氨基]乙基]-,O-甲基酯 异噻唑,4,5-二氯-2,5-二氢-2-辛基- 希诺米啉 四氟硼酸二氢1,3-二(叔-丁基)-4,5--1H-咪唑正离子 四唑硝基紫 噻唑丁炎酮 噻唑,4,5-二氢-4-(1-甲基乙基)-,(S)- 噁唑,4,5-二氢-4,4-二甲基-2-(5-甲基-2-呋喃基)- 噁唑,2-庚基-4,5-二氢- 咪唑烷基脲 吡嗪,2,3-二氢-5,6-二甲基-2-丙基- 叔-丁基3-羟基-1,4,6,7-四氢吡唑并[4,3-c]吡啶-5-羧酸酯 双吡唑啉酮 双[(S)-4-异丙基-4,5-二氢噁唑-2-基]甲烷 双((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)甲烷 利美尼啶D4 利美尼啶 假硫代乙内酰脲 依达拉奉杂质DO 依达拉奉杂质 依达拉奉三聚体 依达拉奉 仲班酸